HOME >> BIOLOGY >> NEWS
Cholesterol Lowering Drugs Stall Disease Progression In People With Below-Average Blood Cholesterol Level

is a widely used noninvasive technique to measure atherosclerosis in the carotid arteries. The degree of narrowing in the carotids is an indication of the amount of atherosclerosis elsewhere in the body. From the scans, the researchers could measure the thickness of the carotid artery wall; an increase in artery thickness over time indicated an increase in atherosclerotic deposits. At the end of four years, 77 percent of the pravastatin and 78 percent of the placebo patients remained in the study. The New Zealand researchers found that the pravastatin group had average total cholesterol of about 39 mg/dL (19 percent) lower than the placebo group. The average increase in carotid artery thickness was 0.048 millimeters (0.00187 inch) in the placebo group and a decrease in thickness of 0.014 millimeters (0.00055 inch) in the pravastatin group. "There was clearly a major difference between the two groups," MacMahon says. "We showed that cholesterol lowering with pravastatin appeared to prevent the progression of atherosclerosis in the carotid artery."

The effect of treatment was the same for those with above-average levels as those with average or below-average levels, according to MacMahon.

The drug group also had 27 percent lower "bad" low-density lipoprotein cholesterol, which is involved in building up artery deposits, and a 19 percent lower apolipoprotein B, a protein associated with "bad" cholesterol. The drug group also had a 13 percent lower level of triglycerides, the chemical form of fat in most foods; four percent higher apolipoprotein A1, a protein that appears to increase heart attack risk; and four percent higher "good" high-density lipoprotein cholesterol, which carries cholesterol away from blood vessel walls.

Does this study indicate that lowering cholesterol with a low fat diet also will prevent atherosclerosis? "Certainly, we would hope that cholesterol lower
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
11-May-1998


Page: 1 2 3

Related biology news :

1. Cholesterol lowering drug effective in treating most common form of multiple sclerosis
2. Cholesterol-independent benefits of statins in cardiac hypertrophy
3. Cholesterol levels not necessarily indicative of cardiac health
4. Women With Low Cholesterol May Be At Risk For Depression And Anxiety
5. Structure Of HDL Cholesterol Determined
6. Discovery Of A Molecule That Controls Bile Acids May Lead To New Cholesterol Drugs
7. Researchers Learn How Nature Produces Cholesterol-Lowering Lovastatin
8. New Insights About Good Cholesterol
9. New Gene May Play Important Role In Regulating HDL, The Good Cholesterol
10. Chinese Condiment Cuts Blood Cholesterol
11. Blue-Green Algae Has Dual Cholesterol Lowering Abilities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 09, 2019 , ... Dr. Beanlands is the Vered ... Ottawa, Ontario, Canada. He is also Director of its National Cardiac PET Centre, ... the Department of Radiology, and in the Department of Cellular and Molecular medicine. , ...
(Date:1/10/2019)... ... January 10, 2019 , ... A major goal ... in vitro studies and significantly more expensive in vivo studies in order to ... To address this need, researchers have begun to adopt 3D cell culture models ...
(Date:1/8/2019)... ... January 07, 2019 , ... PureWay, a healthcare-focused provider ... Thomas Kennedy as head of sales and business development efforts, effective immediately. Mr. ... has previously worked for Johnson & Johnson Medical, Globus Medical, WRP Asia Pacific, ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... POWAY, Calif. (PRWEB) , ... January 22, 2019 , ... ... been using the Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly ... perform VetStem Regenerative Cell Therapy since 2007 and began using V-PET™ 2016. ...
(Date:1/20/2019)... ... ... On January 15 of this year, the Parents’ Guide to Cord Blood website ... M.D., Ph.D. The PGCB was founded by former physicist Dr. Frances Verter, who ... 21st year of operation, the PGCB continues its mission to educate parents with accurate ...
(Date:1/20/2019)... (PRWEB) , ... January 17, 2019 , ... ... and orchestration system software developer, and The Quick Life Science Group (Quick Healthcare ... platform. , The platform enables the global cell and gene therapy industry to ...
(Date:1/11/2019)... ... January 11, 2019 , ... Drawing on over 22 years ... 22, 2019 at 2:30pm EST will explore some of the key lessons that have ... one vendor vs. using multiple vendors, and find out how to ensure that you ...
Breaking Biology Technology:
Cached News: